Abstract
Cancer is one of the leading causes of mortality in developed countries such as the USA. In 1998, there were more than 280,000 and 250,000 cancer related deaths in males and females, respectively. In males, lung and prostate cancers accounted for almost half of these deaths, whereas in females, lung and breast cancers were the leading causes of cancer mortalities. Therefore, the study of cancer has been of the utmost importance to patients, doctors, and researchers alike. A variety of cellular processes occur in the precancerous cells that contribute to the development and progression to cancer. Not surprisingly, all of these cellular processes have been targeted for anticancer therapy. A novel serpin, maspin, has demonstrated a robust effect on a variety of these cancer progression steps. A number of studies have shown that maspin inhibits angiogenesis and tumor cell growth and invasion both in vitro and in vivo. In addition, maspin promotes cell adhesion to the basement membrane and extracellular matrix components. Efforts underway to understand the molecular mechanisms involved in the diverse functions influenced by maspin have yielded promising results and shed light on the cancer pathways.
Keywords: Maspin, Metastasis, Angiogenesis
Current Molecular Medicine
Title: Role of Maspin in Tumor Metastasis and Angiogenesis
Volume: 3 Issue: 7
Author(s): Jeremy S. Schaefer and Ming Zhang
Affiliation:
Keywords: Maspin, Metastasis, Angiogenesis
Abstract: Cancer is one of the leading causes of mortality in developed countries such as the USA. In 1998, there were more than 280,000 and 250,000 cancer related deaths in males and females, respectively. In males, lung and prostate cancers accounted for almost half of these deaths, whereas in females, lung and breast cancers were the leading causes of cancer mortalities. Therefore, the study of cancer has been of the utmost importance to patients, doctors, and researchers alike. A variety of cellular processes occur in the precancerous cells that contribute to the development and progression to cancer. Not surprisingly, all of these cellular processes have been targeted for anticancer therapy. A novel serpin, maspin, has demonstrated a robust effect on a variety of these cancer progression steps. A number of studies have shown that maspin inhibits angiogenesis and tumor cell growth and invasion both in vitro and in vivo. In addition, maspin promotes cell adhesion to the basement membrane and extracellular matrix components. Efforts underway to understand the molecular mechanisms involved in the diverse functions influenced by maspin have yielded promising results and shed light on the cancer pathways.
Export Options
About this article
Cite this article as:
Schaefer S. Jeremy and Zhang Ming, Role of Maspin in Tumor Metastasis and Angiogenesis, Current Molecular Medicine 2003; 3 (7) . https://dx.doi.org/10.2174/1566524033479519
DOI https://dx.doi.org/10.2174/1566524033479519 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Insulin-Like Growth Factor 1 Receptor Targeted Therapeutics: Novel Compounds and Novel Treatment Strategies for Cancer Medicine
Recent Patents on Anti-Cancer Drug Discovery Cannabinoid Receptors as Target for Treatment of Osteoporosis: A Tale of Two Therapies
Current Neuropharmacology The Role of Toll-Like Receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A New Promising Therapeutic Approach?
CNS & Neurological Disorders - Drug Targets Cubosomes: Versatile Nanosized Formulation for Efficient Delivery of Therapeutics
Current Drug Delivery Ovulation, Implantation and Placentation in Females with Obesity and Metabolic Disorders: Life in the Balance
Endocrine, Metabolic & Immune Disorders - Drug Targets Iron Chelators: Development of Novel Compounds with High and Selective Anti-Tumour Activity
Current Drug Delivery Stability and Biological Activity of Human Intestinal Trefoil Factor Produced by Pichia pastoris
Protein & Peptide Letters ZIP4 is a Novel Diagnostic and Prognostic Marker in Human Pancreatic Cancer: A Systemic Comparison Between EUS-FNA and Surgical Specimens
Current Molecular Medicine TRPV1 Activation is Not An All-Or-None Event: TRPV1 Partial Agonism/Antagonism and Its Regulatory Modulation
Current Topics in Medicinal Chemistry Potential Role of MEK Inhibition in Treating Patients with Colorectal Cancer
Current Cancer Therapy Reviews Novobiocin Analogs as Potential Anticancer Agents
Mini-Reviews in Medicinal Chemistry Targeting Mitochondrial Citrate Transport in Breast Cancer Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Recent Updates on the Therapeutic Potential of HER2 Tyrosine Kinase Inhibitors for the Treatment of Breast Cancer
Current Cancer Drug Targets Recent Trends on the Use of Nanoparticles for Nitric Oxide Delivery in Antimicrobial Applications
Drug Delivery Letters Curcumin and Curcumin-like Molecules: From Spice to Drugs
Current Medicinal Chemistry Targeting Established Tumor Vasculature: A Novel Approach to Cancer Treatment
Current Cancer Therapy Reviews Interplay between RNA Methylation Eraser <i>FTO</i> and Writer <i>METTL3</i> in Renal Clear Cell Carcinoma Patient Survival
Recent Patents on Anti-Cancer Drug Discovery Recent Advances in Drug Design of Epidermal Growth Factor Receptor Inhibitors
Current Medicinal Chemistry Characterization of Phosphorylated Proteins Using Mass Spectrometry
Current Protein & Peptide Science The Role of Insulin Receptor Isoforms and Hybrid Insulin/IGF-I Receptors in Human Cancer
Current Pharmaceutical Design